This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bothell, WA (US) (2017)
- Wakefield, MA (US) (2022 - 2024)
- Lynnwood, WA (US) (2024)
Company Filing History:
Years Active: 2017-2026
Title: Simina Crina Petrovan: Innovator in Biopharmaceuticals
Introduction
Simina Crina Petrovan is a distinguished inventor based in Wakefield, MA (US). She has made significant contributions to the field of biopharmaceuticals, holding a total of 6 patents. Her work focuses on the development of innovative therapeutic solutions that enhance the efficacy of recombinant proteins.
Latest Patents
Among her latest patents, one notable invention is related to "Antibodies with modulated glycan profiles." This invention pertains to recombinantly-expressed denosumab molecules and methods for modulating glycan profiles of these molecules. Another significant patent is titled "Methods for increasing mannose content of recombinant proteins," which outlines methods for modulating the mannose content of recombinant proteins, thereby improving their therapeutic potential.
Career Highlights
Simina is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. Her role at Amgen allows her to work on cutting-edge research and development projects that aim to address critical health challenges.
Collaborations
Throughout her career, Simina has collaborated with esteemed colleagues, including Jian Wu and Michael Charles Brandenstein. These collaborations have further enriched her research and contributed to the advancement of biopharmaceutical technologies.
Conclusion
Simina Crina Petrovan is a remarkable inventor whose work in biopharmaceuticals continues to impact the industry positively. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
